May 2026: AI-related sectors at the top
The AI boom lifted global equity markets to new highs in May, despite continued geopolitical unrest. The fund posted a positive month, gaining between 4.5 to 5.5 percent depending on currency and share class. The acquisition of the biotechnology company Esperion was welcomed by the fund. We see medium-term opportunities across all four healthcare subsectors, […]
Monthly comment (Apr 26): A volatile month
In a volatile month, the healthcare sector lagged behind the broader market once again and finished as the second-worst sector in the S&P500. News of increased reimbursements for Medicare Advantage were welcomed by the sector, and healthcare services became the best-performing subsector in April. The fund ended the month down in EUR and SEK, and […]
Monthly comment (Mar 2026): A month dominated by the war in the Middle East
The war in the Middle East dominated the month of March, both in terms of the news flows and the movements on the equity markets. Interest rates rose during the month, reflecting a market that increasingly questioned the likelihood of near-term rate cuts. Diversification, quality, stable growth, and companies with products that address […]
Rhenman & Partners to change service providers
Effective from May 1, 2026, One Fund Management S.A. will take over as the management company and global distributor for the Rhenman & Partners Fund (the “Fund”), replacing FundRock Management Company S.A. and FundRock Distribution S.A respectively. At the same time, Citco Fund Services Luxembourg S.A. will become the new administrator, succeeding UI efa S.A. […]
Rhenman & Partners byter tjänsteleverantörer
Från och med den 1 maj 2026 kommer One Fund Management S.A. att ta över som fondbolag och global distributör för Rhenman & Partners Fund (”Fonden”), och ersätter därmed FundRock Management Company S.A. respektive FundRock Distribution S.A. Samtidigt blir Citco Fund Services Luxembourg S.A. ny administratör och efterträder UI efa S.A. Vad innebär detta? Prospektet […]
Anders Rodebjer joins the Rhenman & Partners’ board
Rhenman & Partners’ board welcomes Anders Rodebjer, a financial industry veteran. He is one of the founders of the corporate finance firm HDR Partners, where he worked for 20 years. Prior to that, he spent 13 years as an investment banker at Carnegie Investment Bank. Anders was also part of an external investor group that […]
Anders Rodebjer ansluter till Rhenman & Partners styrelse
Rhenman & Partners styrelse får ytterligare förstärkning genom Anders Rodebjers tillträde. Anders har en lång bakgrund inom finansbranschen. Han är en av grundarna bakom corporate finance-bolaget HDR Partners där han var verksam i 20 år. Innan dess spenderade han 13 år som investment banker på Carnegie Investment Bank. Anders var även del av en extern […]
Monthly comment (Feb 2026): Strong start to the earnings season
Large-cap pharmaceutical companies performed strongly during the month, driven by solid earnings and the continued momentum for value stocks. Growth stocks underperformed, particularly medical technology and companies perceived as AI losers. M&A activity continued within the biotechnology sector, with the fund benefiting from the acquisition of Arcellx. In the near term, focus shifts from micro […]
Monthly comment (Jan 2026): A relatively weak month as momentum shifted elsewhere
As investors rotated to other sectors, healthcare had a relatively weak month. The continued US dollar sell-off further impacted the healthcare sector. Managed care was especially pressured by a potential lower-than-expected reimbursement rate notice from the Centres for Medicare and Medicaid Services (CMS). The fund had a negative monthly performance, with pharmaceuticals and managed care […]